Katrina J. Church - 20 Dec 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & Chief Compliance Officer
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 20 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 23 Dec 2024, 17:28:12 UTC
Previous filing: 25 Jun 2024
Next filing: 26 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+8,600	+21%	$0.000000	49,799	20 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-8,600	-100%	$0.000000	0	20 Dec 2024	Class A Common Stock	8,600		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs vested 50% on the twelve-month anniversary of the date of grant, and the remaining 50% vested on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date.